Early Phase Cancer Immunotherapy (Current Cancer Research) 1st

Early Phase Cancer Immunotherapy (Current Cancer Research) 1st

$26

by Sandip Pravin Patel

Category:

    Early Phase Cancer Immunotherapy (Current Cancer Research) 1st

    by Sandip Pravin Patel (Editor),‎ Razelle Kurzrock (Editor)

    This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.

     

    Product details

    • Series: Current Cancer Research
    • Hardcover: 331 pages
    • Publisher: Springer; 1st ed. 2018 edition (November 4, 2017)
    • Language: English
    Tags:

Related Products